Comparative evaluation of oral misoprostol and intramuscular oxytocin for active management of the third stage of labor: A prospective study

Background : Postpartum hemorrhage (PPH) is a major cause of maternal morbidity and mortality, especially in low- and middle-income countries. Active management of the third stage of labor (AMTSL) significantly reduces PPH risk, with oxytocin as the first-line uterotonic. However, oxytocin’s reliance on cold-chain storage and skilled administration limits its use in low-resource settings. Misoprostol, being thermostable, easy to administer and suitable for peripheral use, has emerged as a potential alternative. This study compares the efficacy and safety of oral misoprostol (600 mcg) versus intramuscular oxytocin (10 IU) in a tertiary care setting. Materials and Methods : A prospective comparative study was conducted at Dr. D. Y. Patil Medical College Hospital, Pune, from September 2023 to January 2025, including 146 women undergoing vaginal delivery. Participants were randomized to receive either oral misoprostol (n=75) or intramuscular oxytocin (n=71) within one minute of delivery. Primary outcomes included the need for additional uterotonics, surgical interventions and blood transfusions. Secondary outcomes were total blood loss (Brass V drape), hemoglobin and hematocrit changes and adverse effects. Results : Maternal age and gestational age were comparable between groups. Additional uterotonics were needed more in the oxytocin group (19.7% vs. 10.7%, p=0.126). Surgical interventions like manual removal of placenta, exploration and repair of deep perineal and vaginal tears and uterine exploration with tamponade insertion were significantly higher in the oxytocin group (11.3% vs. 2.7%, p=0.040) which were needed for cases of refractory atonic PPH and retained placenta where medical management failed. Blood loss, hematological changes and side effects were similar across groups. Conclusion : Oral misoprostol is as effective as intramuscular oxytocin for AMTSL, with fewer surgical interventions and comparable safety. It is a practical alternative, particularly in low-resource settings.

Authors

Institutions

Publication Details

Journal
Indian Journal of Obstetrics and Gynecology Research
Published
2026-11-17
DOI
https://doi.org/10.18231/j.ijogr.11159.1787026228
Primary Topic
Maternal and fetal healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Comparative evaluation of oral misoprostol and intramuscular oxytocin for active management of the third stage of labor: A prospective study

Shilpa Pankaj Kshirsagar, Sukesh Kumar Kathpalia, Heena Kishore Vaswani
Indian Journal of Obstetrics and Gynecology Research
Maternal and fetal healthcare
article

Comparative evaluation of oral misoprostol and intramuscular oxytocin for active management of the third stage of labor: A prospective study

Shilpa Pankaj Kshirsagar, Sukesh Kumar Kathpalia, Heena Kishore Vaswani
article en

Abstract

Background : Postpartum hemorrhage (PPH) is a major cause of maternal morbidity and mortality, especially in low- and middle-income countries. Active management of the third stage of labor (AMTSL) significantly reduces PPH risk, with oxytocin as the first-line uterotonic. However, oxytocin’s reliance on cold-chain storage and skilled administration limits its use in low-resource settings. Misoprostol, being thermostable, easy to administer and suitable for peripheral use, has emerged as a potential alternative. This study compares the efficacy and safety of oral misoprostol (600 mcg) versus intramuscular oxytocin (10 IU) in a tertiary care setting. Materials and Methods : A prospective comparative study was conducted at Dr. D. Y. Patil Medical College Hospital, Pune, from September 2023 to January 2025, including 146 women undergoing vaginal delivery. Participants were randomized to receive either oral misoprostol (n=75) or intramuscular oxytocin (n=71) within one minute of delivery. Primary outcomes included the need for additional uterotonics, surgical interventions and blood transfusions. Secondary outcomes were total blood loss (Brass V drape), hemoglobin and hematocrit changes and adverse effects. Results : Maternal age and gestational age were comparable between groups. Additional uterotonics were needed more in the oxytocin group (19.7% vs. 10.7%, p=0.126). Surgical interventions like manual removal of placenta, exploration and repair of deep perineal and vaginal tears and uterine exploration with tamponade insertion were significantly higher in the oxytocin group (11.3% vs. 2.7%, p=0.040) which were needed for cases of refractory atonic PPH and retained placenta where medical management failed. Blood loss, hematological changes and side effects were similar across groups. Conclusion : Oral misoprostol is as effective as intramuscular oxytocin for AMTSL, with fewer surgical interventions and comparable safety. It is a practical alternative, particularly in low-resource settings.

Indian Journal of Obstetrics and Gynecology ResearchVol. 13(4)
Dr. D. Y. Patil Medical College, Hospital and Research Centre (IN)
Good health and well-being
Maternal and fetal healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon